SlideShare a Scribd company logo
1 of 18
Download to read offline
1
The Active and Assisted Living (AAL-2)
Joint Programme (JP) - TFEU Art. 185 Initiative
Dr. Rafael De ANDRES MEDINADr. Rafael De ANDRES MEDINA
President of the Ambient Assisted Living AssociationPresident of the Ambient Assisted Living Association
2
 Opportunities for AAL to deliver:
 Benefit for the person and their families.
 Benefit for support and care systems across Europe.
 Benefit for European economies.
 Develop products and services for aging well at home,
in the community and at work.
 Create critical mass of R&D & Innovation at
European level.
 Fostering to create markets through common and
compatible European solutions.
 A growing market segment of discerning consumers.
“An overall objective of the AAL JP is to enhance the quality
of life of older people and strengthen the industrial base in
Europe through the use of Information and Communication
Technologies (ICT) tools systems and services”.
3
Stakeholders with whom AAL JP can cooperate inStakeholders with whom AAL JP can cooperate in
order to undertake the challenges of innovation.order to undertake the challenges of innovation.
4
 What AAL have delivered already.
5
Call 5:
Home Care
Call 3:
Self-Serve Society
Innovation For Our FutureInnovation For Our Future
Call 2:
Social Interaction
Call 4: Mobility
Call 1:
Chronic
Conditions
Call 6:
Occupation in Life
AAL calls 1 – 5: ~ 150 projects funded
6
  AAL JP
Call 1
2008
AAL
JP
Call 2
2009
AAL
JP
Call 3
2010
AAL
JP
Call 4
2011
AAL JP
Call 5
2012
AAL JP
Call 6
2013
FP 7 ICT
programm
e, ICT &
Ageing,
First Call
Large
enterprises
9% 7% 10% 10% 7% 9% 10%
SMEs 38% 46% 49% 52% 44% 47% 19%
User and
other
organisatio
ns
18% 14% 11% 11% 21% 16% 6%
Research
performing
organisatio
ns
19% 21% 19% 14% 12% 15% 35%
Universities 16% 12% 9% 13% 16% 13% 30%
Total 100% 100% 100% 100% 100% 100% 100%
[1]
The data shown for AAL JP are those ones for submitted proposals, and are very similar
to the data for ranked proposals – i.e. those eligible for funding – so the latter data are
excluded.
[2]
Average SME participation in the whole FP7 ICT programme is 14.4% (FP7 report, Spring
2010, EC DG-Research & Innovation).
30% of entities with
an end-user role
AAL Calls 1-6:AAL Calls 1-6: Type of OrganisationsType of Organisations
involvedinvolved inin thethe Submitted projectSubmitted project proposalsproposals
7
Call 6 (2013) proposals invited
for negotiation / reconfigurationIn total, 3,930 users over calls 1 - 5
AAL calls 1-6:AAL calls 1-6: NumberNumber ofof
submitted proposals and funded projectssubmitted proposals and funded projects
Total funding ~ 600 M €, ~ 50 % public funding
(~ half by Partner States and ~ half by EU), ~ 50 % private
funding.
Project Business Plan: Expected time to market after project completion < 3
years.
8
AAL calls 1 - 5AAL calls 1 - 5
FUNCTIONALITIES AAL SOLUTIONS Project
partners
Signal/alarm to professional or informal care 15
Support ADL / independent living / self care 10
Orientation & navigation 9
Cognitive support 7
Monitoring Patient Status 7
Support informal care
(info/advice/e-learning/experiences)
8
Social interaction 4
Surveillance (inside the home) 5
Physical activity / rehabilitation / mobility 4
Contacting people 4
Coordination professional care 4
Surveillance / localisation (outside) 3
Entertainment 2
Geja Langerveld, AAL NCP,
3030 Projects funded on NDProjects funded on ND
9
N° of participanting project partners = 70
N° of SMEs involved = 27 (38,6%)
N° of End-user organizations involved = 17
(24.3%)
Projects, total budget = 24.2 M €
Total Funding (EC + Partner States) = 13.2 M €
99 projects funded on Health and Nutritionprojects funded on Health and Nutrition
AAL calls 1 - 5AAL calls 1 - 5
10
• Action 1: AAL2Business.
o To support AAL JP projects to bring their developed solutions to the
market within 2 to 3 years after the end of the funding period.
• Action 2: Collaboration with Regions.
o Action aiming at facilitating the deployment of AAL solutions, via
workshops with local and regional representatives to raise
awareness of AAL JP projects, to foster exchange of experience
between European regions.
• Action 3: User involvement in AAL JP projects.
o To support AAL JP projects in involving users in the most
appropriate and effective way during research, development and
role-out via current state and analysis of user involvement and
workshops, among other activities.
• Action 4: Standards & Interoperability in AAL.
o To raise awareness about interoperability issues of AAL solutions to
facilitate market uptake.
AAL JP Support ActionsAAL JP Support Actions
11
AAL JP ForaAAL JP Fora
Vienna, Austria (2009)
Participants 722
Exhibitors 23
Posters 75
Sessions 35
Participants 500
Exhibitors
25
Sessions 18
Odense, Denmark (2010)
Lecce, Italy (2011)
Participants 600
Exhibitors 47
Sessions
25
Posters 75
Eindhoven, The
Netherlands (2013)
Participants 1,229
Exhibitors 73
Sponsors 6
Media partners 2
Sessions
44
12
13
 The near future.
14
AAL-2 JP PositioningAAL-2 JP Positioning
Proven
Ideas
Excellent
Science
Societal
Challenges
1
Horizon 2020
New
Knowledge
Joint
Programme
Initiatives
Public Health Programme
European
Structural
Funds
European
Investment
Bank
Deployment support
Active and Healthy Ageing Partnership
Evidence and
innovation
guidelines
Research Innovation Deployment
New solutions
MoreYearsBetter
Lives
Neurodegenerative
Disease
Industrial
Leadership
(includingICT)
HealthDietforHealthy
Life
700 M €
•150 Partner
states
•175 EU
•350 private
15
• Aims at funding the development of ICT-based solutions which enable
and support sustainable care systems for older adults, i.e.
o systems that are socially and economically viable for the future and
which do not result in disproportionate or unfair impacts on any
significant contributory element of the healthcare system.
• targets new concepts necessary to ensure patient centred care with
focus on older adults considering the growing importance of informal
caregivers to deliver future care services and maximising the opportunity
for technologies to support care and new providers to enter the market.
o New solutions to also support prevention, early discharges, reduce
readmissions and sustain health outcomes to regain independent
lifestyles.
• It is anticipated that the call will be launched at the end of March 2014,
with a proposal submission deadline end of June 2014.
o The launch of the call is subject (i.e. regarding EU co-funding) to a
final adoption of the legal base for the AAL-2 Programme by the
European Parliament and the Council (envisaged for early April
2014), followed by the conclusion of the necessary agreements
between the AAL Association, the Partner States of the AAL
Association and the European Commission.   
The AAL call 2014:The AAL call 2014:
Care For The FutureCare For The Future
16
AAL JP Project Consortium must
•must include at least three independent eligible organisations from at
least three different AAL Partner States participating in this AAL call for
Proposals.
•include at least one business partner.
•must include at least one SME partner which can be the business
partner.
•must include at least one end-user organization.
•Compliance of consortium partners to the specific National eligibility
rules too.
The AAL call 2014:The AAL call 2014:
• The proposal must include a business plan.
• Expected time to market < 2-3 years after project end
• Up to 3 M € public funding / 7 M € maximum project budget.
Care For The FutureCare For The Future
Rafael Medina AAL #MWC14 #mHealth
18
•Many thanks
for your attention ¡¡¡
president@aal-europe.eu
http://www.aal-europe.eu

More Related Content

What's hot

The Role of the Living Labs – Co-design to Improve Product Development, Consu...
The Role of the Living Labs – Co-design to Improve Product Development, Consu...The Role of the Living Labs – Co-design to Improve Product Development, Consu...
The Role of the Living Labs – Co-design to Improve Product Development, Consu...European Network of Living Labs (ENoLL)
 
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski at IST...
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski  at IST...Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski  at IST...
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski at IST...European Network of Living Labs (ENoLL)
 
Living Labs, Social Innovation Ecosystems and Collaboratories
Living Labs, Social Innovation Ecosystems and CollaboratoriesLiving Labs, Social Innovation Ecosystems and Collaboratories
Living Labs, Social Innovation Ecosystems and CollaboratoriesArtur Serra
 
Living Labs and the Maker community’s response to the COVID-19 crisis around ...
Living Labs and the Maker community’s response to the COVID-19 crisis around ...Living Labs and the Maker community’s response to the COVID-19 crisis around ...
Living Labs and the Maker community’s response to the COVID-19 crisis around ...European Network of Living Labs (ENoLL)
 
The European Network of Living Labs and ICT for Sustainable Energy
The European Network of Living Labs and ICT for Sustainable EnergyThe European Network of Living Labs and ICT for Sustainable Energy
The European Network of Living Labs and ICT for Sustainable Energyaciddtic21
 
European perspectives on economic social and demographic challenges - Markku ...
European perspectives on economic social and demographic challenges - Markku ...European perspectives on economic social and demographic challenges - Markku ...
European perspectives on economic social and demographic challenges - Markku ...CARER+ Project
 
MARIO Project Presentation - 10 March 2015
MARIO Project Presentation - 10 March 2015MARIO Project Presentation - 10 March 2015
MARIO Project Presentation - 10 March 2015Ilias Trochidis
 
SDGs and PPPs in the Healthcare Sector – New Benchmarks
SDGs and PPPs in the Healthcare Sector –  New BenchmarksSDGs and PPPs in the Healthcare Sector –  New Benchmarks
SDGs and PPPs in the Healthcare Sector – New BenchmarksNatalia Korchakova-Heeb
 

What's hot (20)

Urban Living Lab Presentation
Urban Living Lab PresentationUrban Living Lab Presentation
Urban Living Lab Presentation
 
European Network of Living Labs
European Network of Living Labs European Network of Living Labs
European Network of Living Labs
 
The Role of the Living Labs – Co-design to Improve Product Development, Consu...
The Role of the Living Labs – Co-design to Improve Product Development, Consu...The Role of the Living Labs – Co-design to Improve Product Development, Consu...
The Role of the Living Labs – Co-design to Improve Product Development, Consu...
 
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski at IST...
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski  at IST...Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski  at IST...
Sustainable Living Labs Presentation ENoLL President Tuija Hirvikoski at IST...
 
Making most out of digitalization and citizen engagement
Making most out of digitalization and citizen engagement Making most out of digitalization and citizen engagement
Making most out of digitalization and citizen engagement
 
Introduction to ENoLL
Introduction to ENoLL Introduction to ENoLL
Introduction to ENoLL
 
Global Science, Technology & Innovation Conference
Global Science, Technology & Innovation ConferenceGlobal Science, Technology & Innovation Conference
Global Science, Technology & Innovation Conference
 
Brainstorm session on: Start-up and scale up support
Brainstorm session on: Start-up and scale up supportBrainstorm session on: Start-up and scale up support
Brainstorm session on: Start-up and scale up support
 
OpenLivingLab Days'17 Preparatory Webinar
OpenLivingLab Days'17 Preparatory Webinar OpenLivingLab Days'17 Preparatory Webinar
OpenLivingLab Days'17 Preparatory Webinar
 
Living Labs, Social Innovation Ecosystems and Collaboratories
Living Labs, Social Innovation Ecosystems and CollaboratoriesLiving Labs, Social Innovation Ecosystems and Collaboratories
Living Labs, Social Innovation Ecosystems and Collaboratories
 
Introducing Living Labs and ENoLL
Introducing Living Labs and ENoLLIntroducing Living Labs and ENoLL
Introducing Living Labs and ENoLL
 
Living Labs and the Maker community’s response to the COVID-19 crisis around ...
Living Labs and the Maker community’s response to the COVID-19 crisis around ...Living Labs and the Maker community’s response to the COVID-19 crisis around ...
Living Labs and the Maker community’s response to the COVID-19 crisis around ...
 
The European Network of Living Labs and ICT for Sustainable Energy
The European Network of Living Labs and ICT for Sustainable EnergyThe European Network of Living Labs and ICT for Sustainable Energy
The European Network of Living Labs and ICT for Sustainable Energy
 
Services Of LivingLabs and the European Network of Living Labs (ENoLL)
Services Of  LivingLabs and the European Network of Living Labs (ENoLL)Services Of  LivingLabs and the European Network of Living Labs (ENoLL)
Services Of LivingLabs and the European Network of Living Labs (ENoLL)
 
European perspectives on economic social and demographic challenges - Markku ...
European perspectives on economic social and demographic challenges - Markku ...European perspectives on economic social and demographic challenges - Markku ...
European perspectives on economic social and demographic challenges - Markku ...
 
SIC Launch Event: The state of the union
SIC Launch Event: The state of the union SIC Launch Event: The state of the union
SIC Launch Event: The state of the union
 
MARIO Project Presentation - 10 March 2015
MARIO Project Presentation - 10 March 2015MARIO Project Presentation - 10 March 2015
MARIO Project Presentation - 10 March 2015
 
SIC Launch Event: The state of the union
SIC Launch Event: The state of the unionSIC Launch Event: The state of the union
SIC Launch Event: The state of the union
 
SDGs and PPPs in the Healthcare Sector – New Benchmarks
SDGs and PPPs in the Healthcare Sector –  New BenchmarksSDGs and PPPs in the Healthcare Sector –  New Benchmarks
SDGs and PPPs in the Healthcare Sector – New Benchmarks
 
Citizen Power Station
Citizen Power StationCitizen Power Station
Citizen Power Station
 

Viewers also liked

MPLS-based Metro Ethernet Networks
MPLS-based Metro Ethernet NetworksMPLS-based Metro Ethernet Networks
MPLS-based Metro Ethernet NetworksAPNIC
 
Asynchronous Transfer Mode (ATM)
Asynchronous Transfer Mode (ATM)Asynchronous Transfer Mode (ATM)
Asynchronous Transfer Mode (ATM)Agreeta Sharma
 
ATM Networking Concept
ATM Networking ConceptATM Networking Concept
ATM Networking ConceptTushar Ranjan
 
10 Slides to ATM
10 Slides to ATM10 Slides to ATM
10 Slides to ATMseanraz
 
W-LAN (Wireless Local Area Network)
W-LAN (Wireless Local Area Network)W-LAN (Wireless Local Area Network)
W-LAN (Wireless Local Area Network)Parvesh Taneja
 

Viewers also liked (7)

AAL Forum 2016
AAL Forum 2016AAL Forum 2016
AAL Forum 2016
 
Ethernet tutorial
Ethernet tutorialEthernet tutorial
Ethernet tutorial
 
MPLS-based Metro Ethernet Networks
MPLS-based Metro Ethernet NetworksMPLS-based Metro Ethernet Networks
MPLS-based Metro Ethernet Networks
 
Asynchronous Transfer Mode (ATM)
Asynchronous Transfer Mode (ATM)Asynchronous Transfer Mode (ATM)
Asynchronous Transfer Mode (ATM)
 
ATM Networking Concept
ATM Networking ConceptATM Networking Concept
ATM Networking Concept
 
10 Slides to ATM
10 Slides to ATM10 Slides to ATM
10 Slides to ATM
 
W-LAN (Wireless Local Area Network)
W-LAN (Wireless Local Area Network)W-LAN (Wireless Local Area Network)
W-LAN (Wireless Local Area Network)
 

Similar to Rafael Medina AAL #MWC14 #mHealth

Closing Remarks - AAL Market Observatory Workshop - 22 May 2014
Closing Remarks - AAL Market Observatory Workshop - 22 May 2014Closing Remarks - AAL Market Observatory Workshop - 22 May 2014
Closing Remarks - AAL Market Observatory Workshop - 22 May 2014deboradg
 
HoCare - Interreg Europe project proposal
HoCare - Interreg Europe project proposalHoCare - Interreg Europe project proposal
HoCare - Interreg Europe project proposalJan Kubalík
 
CallforEurope weekly report_extract
CallforEurope weekly report_extractCallforEurope weekly report_extract
CallforEurope weekly report_extractCall4Europe
 
1st issue of LiCEA newsletter
1st issue of LiCEA newsletter1st issue of LiCEA newsletter
1st issue of LiCEA newsletterJan Šašek
 
AAL Programma - Alain Thielemans
AAL Programma - Alain ThielemansAAL Programma - Alain Thielemans
AAL Programma - Alain Thielemansimec
 
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)KTN
 
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)Nordic Innovation
 
FP7 Specific Programme Capacities (March 2007)
FP7 Specific  Programme  Capacities (March 2007)FP7 Specific  Programme  Capacities (March 2007)
FP7 Specific Programme Capacities (March 2007)CPN_Africa
 
Interreg Sudoe TWIST - innovation procurement in water sector
Interreg Sudoe TWIST - innovation procurement in water sectorInterreg Sudoe TWIST - innovation procurement in water sector
Interreg Sudoe TWIST - innovation procurement in water sectorCENTA3
 
Living Labs for user-driven open innovation
Living Labs for user-driven open innovationLiving Labs for user-driven open innovation
Living Labs for user-driven open innovationlimousinlivinglab
 
AAL 2015 Call - by Innoviris
AAL 2015 Call - by InnovirisAAL 2015 Call - by Innoviris
AAL 2015 Call - by Innovirislifetech.brussels
 
Anaxo1wwwwwwwww
Anaxo1wwwwwwwwwAnaxo1wwwwwwwww
Anaxo1wwwwwwwwwamautajara
 
FRACTALS introduction - Innovative ideas for the farm of the future
FRACTALS introduction - Innovative ideas for the farm of the futureFRACTALS introduction - Innovative ideas for the farm of the future
FRACTALS introduction - Innovative ideas for the farm of the futureTechnology Park Ljubljana
 
FRACTALS FIWARE Accelerator: Introduction
FRACTALS FIWARE Accelerator: IntroductionFRACTALS FIWARE Accelerator: Introduction
FRACTALS FIWARE Accelerator: IntroductionGrigoris Chatzikostas
 
Startup Korea Roundtable 2Q 2015_France
Startup Korea Roundtable 2Q 2015_FranceStartup Korea Roundtable 2Q 2015_France
Startup Korea Roundtable 2Q 2015_FranceD.CAMP
 
FIWAREPamplona - Training Day - Orizont Agrifood Accelerator
FIWAREPamplona - Training Day - Orizont Agrifood AcceleratorFIWAREPamplona - Training Day - Orizont Agrifood Accelerator
FIWAREPamplona - Training Day - Orizont Agrifood AcceleratorMiguel García González
 

Similar to Rafael Medina AAL #MWC14 #mHealth (20)

Closing Remarks - AAL Market Observatory Workshop - 22 May 2014
Closing Remarks - AAL Market Observatory Workshop - 22 May 2014Closing Remarks - AAL Market Observatory Workshop - 22 May 2014
Closing Remarks - AAL Market Observatory Workshop - 22 May 2014
 
HoCare - Interreg Europe project proposal
HoCare - Interreg Europe project proposalHoCare - Interreg Europe project proposal
HoCare - Interreg Europe project proposal
 
CallforEurope weekly report_extract
CallforEurope weekly report_extractCallforEurope weekly report_extract
CallforEurope weekly report_extract
 
1st issue of LiCEA newsletter
1st issue of LiCEA newsletter1st issue of LiCEA newsletter
1st issue of LiCEA newsletter
 
AAL Programma - Alain Thielemans
AAL Programma - Alain ThielemansAAL Programma - Alain Thielemans
AAL Programma - Alain Thielemans
 
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)
Overview of Horizon Europe Clusters - Webinar Series | Health (Cluster 1)
 
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)
Public procurement and innovation - Suzan Ikävalko (Culminatum Innovation)
 
FP7 Specific Programme Capacities (March 2007)
FP7 Specific  Programme  Capacities (March 2007)FP7 Specific  Programme  Capacities (March 2007)
FP7 Specific Programme Capacities (March 2007)
 
Interreg Sudoe TWIST - innovation procurement in water sector
Interreg Sudoe TWIST - innovation procurement in water sectorInterreg Sudoe TWIST - innovation procurement in water sector
Interreg Sudoe TWIST - innovation procurement in water sector
 
Living Labs for user-driven open innovation
Living Labs for user-driven open innovationLiving Labs for user-driven open innovation
Living Labs for user-driven open innovation
 
AAL 2015 Call - by Innoviris
AAL 2015 Call - by InnovirisAAL 2015 Call - by Innoviris
AAL 2015 Call - by Innoviris
 
WORKSHOP 9 DIC 2011 - Agrimi
WORKSHOP 9 DIC 2011 - AgrimiWORKSHOP 9 DIC 2011 - Agrimi
WORKSHOP 9 DIC 2011 - Agrimi
 
Anaxo1wwwwwwwww
Anaxo1wwwwwwwwwAnaxo1wwwwwwwww
Anaxo1wwwwwwwww
 
FRACTALS introduction - Innovative ideas for the farm of the future
FRACTALS introduction - Innovative ideas for the farm of the futureFRACTALS introduction - Innovative ideas for the farm of the future
FRACTALS introduction - Innovative ideas for the farm of the future
 
EPA Horizon 2020 SC5 Roadshow presentation - DCU 11.06.15
EPA Horizon 2020 SC5 Roadshow presentation - DCU 11.06.15EPA Horizon 2020 SC5 Roadshow presentation - DCU 11.06.15
EPA Horizon 2020 SC5 Roadshow presentation - DCU 11.06.15
 
FRACTALS FIWARE Accelerator: Introduction
FRACTALS FIWARE Accelerator: IntroductionFRACTALS FIWARE Accelerator: Introduction
FRACTALS FIWARE Accelerator: Introduction
 
Startup Korea Roundtable 2Q 2015_France
Startup Korea Roundtable 2Q 2015_FranceStartup Korea Roundtable 2Q 2015_France
Startup Korea Roundtable 2Q 2015_France
 
Dr. csaba forgarassy
Dr. csaba forgarassyDr. csaba forgarassy
Dr. csaba forgarassy
 
EPA Horizon 2020 SC5 Roadshow presentation - UCD 02.06.15
EPA Horizon 2020 SC5 Roadshow presentation - UCD 02.06.15EPA Horizon 2020 SC5 Roadshow presentation - UCD 02.06.15
EPA Horizon 2020 SC5 Roadshow presentation - UCD 02.06.15
 
FIWAREPamplona - Training Day - Orizont Agrifood Accelerator
FIWAREPamplona - Training Day - Orizont Agrifood AcceleratorFIWAREPamplona - Training Day - Orizont Agrifood Accelerator
FIWAREPamplona - Training Day - Orizont Agrifood Accelerator
 

More from 3GDR

Longevity Summit Dublin HorseTech presentation by David Doherty.pdf
Longevity Summit Dublin HorseTech presentation by David Doherty.pdfLongevity Summit Dublin HorseTech presentation by David Doherty.pdf
Longevity Summit Dublin HorseTech presentation by David Doherty.pdf3GDR
 
HorseTech Conference Cheltenham Topics/Speakers
HorseTech Conference Cheltenham Topics/Speakers HorseTech Conference Cheltenham Topics/Speakers
HorseTech Conference Cheltenham Topics/Speakers 3GDR
 
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...3GDR
 
How would the Born Mobile redesign Medicine and the future role of the Doctor.
How would the Born Mobile redesign Medicine and the future role of the Doctor.How would the Born Mobile redesign Medicine and the future role of the Doctor.
How would the Born Mobile redesign Medicine and the future role of the Doctor.3GDR
 
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 20193GDR
 
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 20193GDR
 
Mobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered PatientsMobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered Patients3GDR
 
Mobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered PatientsMobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered Patients3GDR
 
The Future Role of the Doctor
The Future Role of the DoctorThe Future Role of the Doctor
The Future Role of the Doctor3GDR
 
How would the Born Mobile redesign Medicine
How would the Born Mobile redesign MedicineHow would the Born Mobile redesign Medicine
How would the Born Mobile redesign Medicine3GDR
 
Introduction to gdpr
Introduction to gdprIntroduction to gdpr
Introduction to gdpr3GDR
 
Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.43GDR
 
Alan Connor, eHealth Ireland
Alan Connor, eHealth IrelandAlan Connor, eHealth Ireland
Alan Connor, eHealth Ireland3GDR
 
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)3GDR
 
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)3GDR
 
Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...3GDR
 
5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 3GDR
 
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...3GDR
 
Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...3GDR
 
The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...3GDR
 

More from 3GDR (20)

Longevity Summit Dublin HorseTech presentation by David Doherty.pdf
Longevity Summit Dublin HorseTech presentation by David Doherty.pdfLongevity Summit Dublin HorseTech presentation by David Doherty.pdf
Longevity Summit Dublin HorseTech presentation by David Doherty.pdf
 
HorseTech Conference Cheltenham Topics/Speakers
HorseTech Conference Cheltenham Topics/Speakers HorseTech Conference Cheltenham Topics/Speakers
HorseTech Conference Cheltenham Topics/Speakers
 
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...
 
How would the Born Mobile redesign Medicine and the future role of the Doctor.
How would the Born Mobile redesign Medicine and the future role of the Doctor.How would the Born Mobile redesign Medicine and the future role of the Doctor.
How would the Born Mobile redesign Medicine and the future role of the Doctor.
 
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
 
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 2019
 
Mobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered PatientsMobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered Patients
 
Mobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered PatientsMobile Health: the enable of Empowered Patients
Mobile Health: the enable of Empowered Patients
 
The Future Role of the Doctor
The Future Role of the DoctorThe Future Role of the Doctor
The Future Role of the Doctor
 
How would the Born Mobile redesign Medicine
How would the Born Mobile redesign MedicineHow would the Born Mobile redesign Medicine
How would the Born Mobile redesign Medicine
 
Introduction to gdpr
Introduction to gdprIntroduction to gdpr
Introduction to gdpr
 
Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4
 
Alan Connor, eHealth Ireland
Alan Connor, eHealth IrelandAlan Connor, eHealth Ireland
Alan Connor, eHealth Ireland
 
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
 
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
 
Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...
 
5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare
 
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...
 
Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...
 
The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...
 

Recently uploaded

Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeQuick MedTalk
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONojaswinihemane
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersSai Sailesh Kumar Goothy
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 

Recently uploaded (20)

Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disorders
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 

Rafael Medina AAL #MWC14 #mHealth

  • 1. 1 The Active and Assisted Living (AAL-2) Joint Programme (JP) - TFEU Art. 185 Initiative Dr. Rafael De ANDRES MEDINADr. Rafael De ANDRES MEDINA President of the Ambient Assisted Living AssociationPresident of the Ambient Assisted Living Association
  • 2. 2  Opportunities for AAL to deliver:  Benefit for the person and their families.  Benefit for support and care systems across Europe.  Benefit for European economies.  Develop products and services for aging well at home, in the community and at work.  Create critical mass of R&D & Innovation at European level.  Fostering to create markets through common and compatible European solutions.  A growing market segment of discerning consumers. “An overall objective of the AAL JP is to enhance the quality of life of older people and strengthen the industrial base in Europe through the use of Information and Communication Technologies (ICT) tools systems and services”.
  • 3. 3 Stakeholders with whom AAL JP can cooperate inStakeholders with whom AAL JP can cooperate in order to undertake the challenges of innovation.order to undertake the challenges of innovation.
  • 4. 4  What AAL have delivered already.
  • 5. 5 Call 5: Home Care Call 3: Self-Serve Society Innovation For Our FutureInnovation For Our Future Call 2: Social Interaction Call 4: Mobility Call 1: Chronic Conditions Call 6: Occupation in Life AAL calls 1 – 5: ~ 150 projects funded
  • 6. 6   AAL JP Call 1 2008 AAL JP Call 2 2009 AAL JP Call 3 2010 AAL JP Call 4 2011 AAL JP Call 5 2012 AAL JP Call 6 2013 FP 7 ICT programm e, ICT & Ageing, First Call Large enterprises 9% 7% 10% 10% 7% 9% 10% SMEs 38% 46% 49% 52% 44% 47% 19% User and other organisatio ns 18% 14% 11% 11% 21% 16% 6% Research performing organisatio ns 19% 21% 19% 14% 12% 15% 35% Universities 16% 12% 9% 13% 16% 13% 30% Total 100% 100% 100% 100% 100% 100% 100% [1] The data shown for AAL JP are those ones for submitted proposals, and are very similar to the data for ranked proposals – i.e. those eligible for funding – so the latter data are excluded. [2] Average SME participation in the whole FP7 ICT programme is 14.4% (FP7 report, Spring 2010, EC DG-Research & Innovation). 30% of entities with an end-user role AAL Calls 1-6:AAL Calls 1-6: Type of OrganisationsType of Organisations involvedinvolved inin thethe Submitted projectSubmitted project proposalsproposals
  • 7. 7 Call 6 (2013) proposals invited for negotiation / reconfigurationIn total, 3,930 users over calls 1 - 5 AAL calls 1-6:AAL calls 1-6: NumberNumber ofof submitted proposals and funded projectssubmitted proposals and funded projects Total funding ~ 600 M €, ~ 50 % public funding (~ half by Partner States and ~ half by EU), ~ 50 % private funding. Project Business Plan: Expected time to market after project completion < 3 years.
  • 8. 8 AAL calls 1 - 5AAL calls 1 - 5 FUNCTIONALITIES AAL SOLUTIONS Project partners Signal/alarm to professional or informal care 15 Support ADL / independent living / self care 10 Orientation & navigation 9 Cognitive support 7 Monitoring Patient Status 7 Support informal care (info/advice/e-learning/experiences) 8 Social interaction 4 Surveillance (inside the home) 5 Physical activity / rehabilitation / mobility 4 Contacting people 4 Coordination professional care 4 Surveillance / localisation (outside) 3 Entertainment 2 Geja Langerveld, AAL NCP, 3030 Projects funded on NDProjects funded on ND
  • 9. 9 N° of participanting project partners = 70 N° of SMEs involved = 27 (38,6%) N° of End-user organizations involved = 17 (24.3%) Projects, total budget = 24.2 M € Total Funding (EC + Partner States) = 13.2 M € 99 projects funded on Health and Nutritionprojects funded on Health and Nutrition AAL calls 1 - 5AAL calls 1 - 5
  • 10. 10 • Action 1: AAL2Business. o To support AAL JP projects to bring their developed solutions to the market within 2 to 3 years after the end of the funding period. • Action 2: Collaboration with Regions. o Action aiming at facilitating the deployment of AAL solutions, via workshops with local and regional representatives to raise awareness of AAL JP projects, to foster exchange of experience between European regions. • Action 3: User involvement in AAL JP projects. o To support AAL JP projects in involving users in the most appropriate and effective way during research, development and role-out via current state and analysis of user involvement and workshops, among other activities. • Action 4: Standards & Interoperability in AAL. o To raise awareness about interoperability issues of AAL solutions to facilitate market uptake. AAL JP Support ActionsAAL JP Support Actions
  • 11. 11 AAL JP ForaAAL JP Fora Vienna, Austria (2009) Participants 722 Exhibitors 23 Posters 75 Sessions 35 Participants 500 Exhibitors 25 Sessions 18 Odense, Denmark (2010) Lecce, Italy (2011) Participants 600 Exhibitors 47 Sessions 25 Posters 75 Eindhoven, The Netherlands (2013) Participants 1,229 Exhibitors 73 Sponsors 6 Media partners 2 Sessions 44
  • 12. 12
  • 13. 13  The near future.
  • 14. 14 AAL-2 JP PositioningAAL-2 JP Positioning Proven Ideas Excellent Science Societal Challenges 1 Horizon 2020 New Knowledge Joint Programme Initiatives Public Health Programme European Structural Funds European Investment Bank Deployment support Active and Healthy Ageing Partnership Evidence and innovation guidelines Research Innovation Deployment New solutions MoreYearsBetter Lives Neurodegenerative Disease Industrial Leadership (includingICT) HealthDietforHealthy Life 700 M € •150 Partner states •175 EU •350 private
  • 15. 15 • Aims at funding the development of ICT-based solutions which enable and support sustainable care systems for older adults, i.e. o systems that are socially and economically viable for the future and which do not result in disproportionate or unfair impacts on any significant contributory element of the healthcare system. • targets new concepts necessary to ensure patient centred care with focus on older adults considering the growing importance of informal caregivers to deliver future care services and maximising the opportunity for technologies to support care and new providers to enter the market. o New solutions to also support prevention, early discharges, reduce readmissions and sustain health outcomes to regain independent lifestyles. • It is anticipated that the call will be launched at the end of March 2014, with a proposal submission deadline end of June 2014. o The launch of the call is subject (i.e. regarding EU co-funding) to a final adoption of the legal base for the AAL-2 Programme by the European Parliament and the Council (envisaged for early April 2014), followed by the conclusion of the necessary agreements between the AAL Association, the Partner States of the AAL Association and the European Commission.    The AAL call 2014:The AAL call 2014: Care For The FutureCare For The Future
  • 16. 16 AAL JP Project Consortium must •must include at least three independent eligible organisations from at least three different AAL Partner States participating in this AAL call for Proposals. •include at least one business partner. •must include at least one SME partner which can be the business partner. •must include at least one end-user organization. •Compliance of consortium partners to the specific National eligibility rules too. The AAL call 2014:The AAL call 2014: • The proposal must include a business plan. • Expected time to market < 2-3 years after project end • Up to 3 M € public funding / 7 M € maximum project budget. Care For The FutureCare For The Future
  • 18. 18 •Many thanks for your attention ¡¡¡ president@aal-europe.eu http://www.aal-europe.eu